Patents/Assignees

Theriva Biologics, Inc.

13 patents in portfolio

US12508304utility2025
Alkaline Phosphatase Formulations
0 cites
US12472147utility2025
Intestinal Alkaline Phosphatase Formulations
0 cites
US12318434utility2025
Alkaline Phosphate-based Oncology Treatments
0 cites
US12274740utility2025
Microbiome Protection from Oral Antibiotics
0 cites
US12178917utility2024
Beta-lactamase Formulations and Uses Thereof
0 cites
US12048735utility2024
Alkaline Phosphatase Formulations
0 cites
US11981899utility2024
E. Coli -based Production of Beta-lactamase
0 cites
US11944669utility2024
Method and Compositions for Inhibiting or Preventing Adverse Effects of Oral Antibiotics
0 cites
US11883474utility2024
Microbiome Protection from Oral Antibiotics
0 cites
US11872268utility2024
Safe and Effective Beta-lactamase Dosing for Microbiome Protection
0 cites
US11654184utility2023
Alkaline Phosphatase Agents for Treatment of Radiation Disorders
0 cites
US11638699utility2023
Intestinal Alkaline Phosphatase Formulations
0 cites
US11608494utility2023
Beta-lactamases with Improved Properties for Therapy
0 cites